| mRNA |
QL-XI-92 |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
2e-09 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
6e-09 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-08 |
| mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
3e-08 |
| mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
4e-08 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
7e-08 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-07 |
| mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-07 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
5e-07 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |